The principals behind the federal Operation Warp Speed initiative expressed optimism yesterday that the Food and Drug Administration could soon authorize two safe and highly effective COVID-19 vaccines. The panel said it expects approximately 40 million doses of the two vaccine candidates to be available for distribution in the U.S. by the end of December.

"Production, of course, would continue to ramp up after that," said Health and Human Services Secretary Alex Azar, noting that, in addition to supporting the development of vaccine candidates, Operation Warp Speed is focused on the allocation, distribution, administration and ongoing monitoring and data work for approved vaccines.

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…